Tocilizumab: from the rheumatology practice to the fight against COVID-19, a virus infection with multiple faces

著录项

• 来源
  《Expert opinion on biological therapy》 |2020年第12期|717-723|共7页
• 作者

  Gonzalez-Gay Miguel A.; Mayo Jose; Castaneda SantosCifrian Jose M.Hernandez-Rodriguez Jose;

  展开▼
• 作者单位

  Hosp Univ Marques Valdecilla, Div Rheumatol & Epidemiol, Genet & Atherosclerosis Res Grp System;

  Galdakao Usansolo Hosp, Infect Dis Unit, Galdakao, Bizkaia, Spain;

  Univ Autonoma Madrid UAM, Hosp La Princesa, Rheumatol Div, IIS Princesa,Catedra UAM Roche,EPIDHosp Univ Marques Valdecilla, IDIVAL, Div Pneumol, Santander, SpainUniv Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin Barcelona, Vasculitis Res;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 英语
• 中图分类 治疗学;
• 关键词

  Chimeric antigen receptor (CAR) T cell-induced cytokine release syndrome; coronavirus; COVID-19; inflammation; interleukin-6; macrophage activation syndrome; tocilizumab; anakinra; colchicine;